Sign In

Treatment of Hepatitis C Infection

Simplified HCV Treatment for All HCV Genotypes

Lesson 1. Simplified HCV Treatment for All HCV Genotypes

 Next Back

Learning Objective Performance Indicators

  • Summarize the eligibility criteria for the American Association for the Study of Liver Disease/Infectious Diseases Society of America (AASLD/IDSA) simplified HCV treatment algorithm
  • Discuss how to assess liver fibrosis, including identifying decompensated cirrhosis
  • List the direct-acting antiviral (DAA) treatment regimens recommended as part of the AASLD/IDSA simplified guidance
  • Describe on-treatment monitoring for adults during HCV treatment using the simplified AASLD/IDSA guidance
  • Describe appropriate post-treatment monitoring for adults after completing HCV treatment

About this Lesson

Learning Objective Performance Indicators

  • Summarize the eligibility criteria for the American Association for the Study of Liver Disease/Infectious Diseases Society of America (AASLD/IDSA) simplified HCV treatment algorithm
  • Discuss how to assess liver fibrosis, including identifying decompensated cirrhosis
  • List the direct-acting antiviral (DAA) treatment regimens recommended as part of the AASLD/IDSA simplified guidance
  • Describe on-treatment monitoring for adults during HCV treatment using the simplified AASLD/IDSA guidance
  • Describe appropriate post-treatment monitoring for adults after completing HCV treatment

Activities in this Lesson

 Next Back

Share by e-mail

Check
-On-
Learning
Questions
The Check-on-Learning Questions are short and topic related. They are meant to help you stay on track throughout each lesson and check your understanding of key concepts.

You must be signed in to customize your interaction with these questions.

Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.